EMCURE PHARMACEUTICALS LIMITED

Scale -

Revenue is 9204 Rs Cr; Annual Growth is 17 %; Continuous Growth over 3 years; 5 Year CAGR is 12 %
Ebitda is 1877 Rs Cr; Annual Growth is 22 %; Continuous Growth over 3 years
PBT is 394 Rs Cr; Annual Growth is 33 %; Continuous Growth over 3 years
PAT is 941 Rs Cr; Annual Growth is 33 %; Continuous Growth over 3 years
Quarterly Revenue is 2580 Rs Cr; Continuous Growth over 3 Quarters

Profitability -

PAT Margin is 10.22 %; Annual Growth is 14 %; Continuous Growth over 3 years; in Bottom Quartile
PBDIT Margin is 20.39 %; Continuous Growth over 3 years; in Bottom Quartile
Quarterly Profit margin is 11 %; Continuous Growth over 3 Quarters

Return -

ROCE is 25.65 %; Annual Growth is 23 %
ROE is 18.67 %; Annual Growth is 22 %
ROA is 9.61 %; Continuous Growth over 3 years
Asset Turnover is 103 %; Continuous Growth over 3 years; in Top Quartile

Efficiency -

Current Ratio is 1.43; in Bottom Quartile
Quick Ratio is 0.82; in Bottom Quartile

Solvancy -

Debt/Equity is 0.24; 5 Year CAGR is -31 %; Annual Growth is 50 %
Long term Debt is 252 Rs Cr; 5 Year CAGR is -23 %; Annual Growth is 33 %

Total Debt is 1204 Rs Cr; Annual Growth is 65 %
Contingent Liabilities is 402 Rs Cr; 5 Year CAGR is 31 %

Quality -

Exceptional Items/PBT is -2 %; Annual Decline is -128 %
Change in Inventories/Total Expenses is -5 %; Annual Decline is -45 %; Continuous Decline over 3 years; in Bottom Quartile

Operating cashflow/ebitda is 50 %; Continuous Decline over 3 years; in Bottom Quartile
Operating cashflow/PAT is 100 %; Continuous Decline over 3 years
Current Tax/PAT is 42 %; Continuous Growth over 3 years; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: